Clinical study to evaluate the effect of a unani formulation of tila in melasma
Phase 2
- Conditions
- Health Condition 1: L811- Chloasma
- Registration Number
- CTRI/2024/02/062478
- Lead Sponsor
- Central Council for Research in Unani Medicine New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically diagnosed patients of Kalaf.
Patients irrespective of gender.
Patients in the age group of 18 to 60 years
Exclusion Criteria
Known cases of skin allergy or sensitivity as revealed by history and clinical examintaion.
Pregnant and Lactating Women and Patients on Oral Contraceptives.
Diseases requiring long term treatments (Including Uncontrolled Diabetes Mellitus, Cardiovascular Diseases, Chronic Renal Diseases, Chronic Liver Diseases) Diagnosed by History of patient and Clinical Examination.
Unwillingness or inability to fill the protocol.
Patients who fail to give the informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Brown and Black Pigmentation measure by physicians assessment scale. <br/ ><br>Irregular, sharp, black and brown hyperpigmented macules measure by Likert Scale.Timepoint: day 0, day 7, day 14 , day 21 and day 29
- Secondary Outcome Measures
Name Time Method photographs of the hyperpigmented macules or lesion. Identity and also the photographs clicked will be placed in such a manner that his or her eyes are not revealed and hence the confidentiality will be maintained. <br/ ><br>Melasma Area Severity Index (MASI)Timepoint: day 0 and day 29